Skip to main content

Profiles

NanoVation Therapeutics

NanoVation Therapeutics Inc. (NTx) is a Canadian biotechnology company based in Vancouver, British Columbia, with an additional operation at the Research Complex at Harwell in the United Kingdom.[1] It is focused on gene therapy and the development of "next-generation" lipid nanoparticles (LNP). It is a spin-off company of the NanoMedicines Innovation Network (NMIN).[2]

History

NTx was co-founded by Dominik Witzigmann and Jayesh Kulkarni.[2:1] The company was incorporated in British Columbia on September 3, 2020, and in the United Kingdom on December 7, 2021.[3][4]

On April 20, 2022, NTx announced its expansion into the United Kingdom by launching its so-called "NanoVation GENErator" at the Harwell Science and Innovation Campus in Oxfordshire, England.[2:2]

Innovate BC announced on September 29, 2022, that NTx would receive a $300,000 grant to further the development of mRNA vaccines.[5]

Organization

NTx is a member organization of Life Sciences British Columbia.[6]

Personnel

Name Position Notes
Marco Ciufolini Co-founder, Vice President, and Board Director (Canada)[7] Rice University, Claude Bernard University Lyon 1, University of British Columbia (UBC)
Pieter Cullis Co-founder, Board Chair (Canada), and Board Director (United Kingdom)[8] Acuitas Therapeutics, UBC Department of Biochemistry & Molecular Biology, adMare BioInnovations, NanoMedicines Innovation Network (NMIN), Royal Society
Eric Jan Co-founder and Board Director (Canada)[7:1] UBC Department of Biochemistry & Molecular Biology, Stanford University
Jayesh Kulkarni Co-founder and Chief Scientific Officer[2:3][7:2] NanoMedicines Innovation Network (NMIN), Northern Lipids, BC Cancer Agency, University of British Columbia (UBC), Evonik, NanoMedicines Research Group
Dominik Witzigmann Co-founder and CEO[2:4][7:3] NanoMedicines Innovation Network (NMIN), UCL School of Pharmacy, German Cancer Research Center, University of Basel Department of Pharmaceutical Sciences, Schwank Lab, University of British Columbia (UBC),[9] Controlled Release Society (CRS), Biozentrum, Swiss Nanoscience Institute (NSI)[10], European Society for Nanomedicine, Swiss Academy of Pharmaceutical Sciences, German Pharmaceutical Society (DPhG)
Marion Athané Marketing & Events Manager[11] NanoMedicines Innovation Network (NMIN)[12]
N. D. Prasad Atmuri Associate Principal Scientist, Chemistry[7:4] University College London (UCL), University of Oxford, Hetero, Syngene, University of Montreal, University of British Columbia (UBC), StrongerBC, Mitacs[13]
Martin Attwood Senior Scientist, Biology[7:5] University College London (UCL), University of Oxford
Hanna Barriga Consultant, Biophysics[7:6] Imperial College London (ICL), Karolinska Institute, Pfizer, Swedish Neutron Scattering Society (SNSS), KTH Royal Institute of Technology, New York Academy of Sciences[14]
Marshall Beck Communications and IT Consultant[7:7] NanoMedicines Innovation Network (NMIN), Centre for Research on Latin America and the Caribbean (CERLAC), CHILD Cohort Study, Centre for Refugee Studies (CRS), North American Congress on Latin America (NACLA)[15]
Mayara Brandao Senior Manager, People and Culture[7:8] VanHack, Community Living Society (CLS), Footprints Recruiting, Recife Center for Advanced Studies and Systems (CESAR), Grupo Contax[16]
David Broemeling Vice President of Operations[7:9] Boreal Genomics, Creative Destruction Lab (CDL), University of British Columbia (UBC), Natera[17]
Frederick Campbell Scientific Director, UK[18] University College London (UCL), Leiden University[19]
Tony Cheung Vice President of Finance[7:10] TIR Systems, Pacific Cellular, Lignol Energy Corporation, Evonik, Portable Electric, Transferra Nanosciences, Canadian Fishing Company (Canfisco), Scouts Canada[20]
Christine DeMatteis Lab Manager[7:11] Zymeworks, CARO Analytical Services[21]
Arpan Desai Managing Director, UK (March 2022-January 2024)[2:5][22] Visiongain, University of Melbourne, University of Nottingham, AstraZeneca, CamGene Therapeutics
Allison Enjetti Senior Project Manager[7:12] AbCellera, U.S. President's Malaria Initiative, British Columbia Centre for Excellence in HIV/AIDS[23]
Don Enns Chief Business Officer[7:13] Molecular You, Evonik, Life Sciences British Columbia, Genome British Columbia[24]
Julia Ayano Fernando Scientist, Biology[7:14] HKU-Pasteur Research Pole, Swansea University
Bruno Fonseca RNA Director[7:15] University of British Columbia (UBC), McGill University, AstraZeneca, Children's Hospital of Eastern Ontario (CHEO), Biologic and Radiopharmaceutical Drugs Directorate (BRDD), PrimerGen[25]
Georgina Girt Senior Scientist, Formulation (UK)[7:16] University of Oxford, Rosalind Franklin Institute (RFI), University of Leicester[26]
Rupsa Gupta Senior Associate Scientist, Formulation[7:17] Precision NanoSystems, NanoMat, Mitacs, Lower Mainland Bengali Cultural Society[27]
Graham Hayes Senior Scientist, Formulation[7:18] Infineum, University of Warwick[28]
Kate Hollinshead Senior Scientist, Translational Science[29] MedImmune, AstraZeneca, NYU Langone Health
Joshua Jeyakumar Patent Associate[7:19] Intellectual Property Institute of Canada (IPIC), MaxVal Group, Effectual Services, Stellarix Consultancy Services[30]
Japneet Kaur Preclinical Research Technician[7:20] -
Daniel Kurek Senior Scientist III, Formulation, Team Lead[7:21] University of Utah, BC Research, University of British Columbia (UBC), Evonik[31]
Wendy Lamson Chief Intellectual Property Officer[7:22] Intellectual Property Institute of Canada (IPIC), University of Ottawa, Lamson IP, Perley-Robertson, Hill & McDougall, Kirby Eades Gale Baker, Iogen, Celator Pharmaceuticals[32]
Rafaela Marodin Senior Research Associate, Formulation[7:23] Simon Fraser University (SFU), Renaissance BioScience, University of British Columbia (UBC), adMare BioInnovations[33]
Michelle Martin Human Resources Consultant[7:24] Forbes Medi-Tech, thriveHR, Aquinox Pharmaceuticals[34]
Nigel McKenzie Senior Manager, Operations[7:25] Natera, Celtic Reforestation, Quest University, BC Wildfire Service, Tübify Foods, SPUD, Smash + Tess, WERD Magazine, Momenta[35]
Lívia Palmerston Mendes Senior Scientist I, Formulation[7:26] Federal University of Goiás, Cifarma Científica Farmacêutica, Antimicrobial Discovery Center (ADC), Northeastern University, CureVac, Controlled Release Society, Abroaders[36]
Ardalan Nabi Scientist I, Chemistry[7:27] UBC Department of Chemistry, Soran University, University of Auckland[37]
Ariane Nissenbaum Senior Associate Scientist, RNA[7:28] Sunnybrook Health Sciences Centre, College of San Mateo (CSM), Atlantis, San Francisco State University, University of California, San Francisco (UCSF), Genentech, UCSF Benioff Children's Hospital at Mission Bay[38]
Maryam Osooly Preclinical Research Technician[7:29] BC Cancer Research Centre (BCCRC)
Grishma Pawar Scientist II, Preclinical[7:30] Krembil Brain Institute (KBI), Maneesh Pharmaceuticals, Vivekanand Education Society College of Pharmacy, Sanofi, Northeastern University, Kalia Labs, University Health Network Postdoc Association (UHNPA), Indian Pharmaceutical Association (IPA)[39]
Nicola Pett Preclinical Research Associate[7:31] University of Calgary, University of Queensland
Atul Rangadurai Scientist I, RNA[7:32] University of Toronto, SickKids, Indian Institute of Science (IISc)[40]
Eleonore Rayner Project Manager[7:33] University of British Columbia (UBC), Hammersmith Medicines Research (HMR), Kastrup Lab, Michael Smith Laboratories[41]
Fariba Saadati Senior Scientist III, Chemistry[7:34] University of British Columbia (UBC), Institute for Advanced Studies in Basic Sciences (IASBS)
Jessica Silva Scientist, Preclinical Immunology[7:35] University of Tennessee at Martin, UBC Department of Microbiology and Immunology, Ronald McDonald House Charities, Phi Eta Sigma, Phi Kappa Phi[42]
Molly Stevens Scientific Advisor (Canada) and Board Member (UK)[43] Imperial College London (ICL), Karolinska Institute, Royal Society, Royal Academy of Engineering, National Academy of Engineering (NAE)
Anthony Tam Scientist II, Preclinical Research[7:36] Vancouver Biotech Limited (VBL), British Columbia Institute of Technology (BCIT), University of British Columbia (UBC), Centre for Heart Lung Innovation (HLI), Mitacs[44]
Huy Tran Scientist II, Chemistry[7:37] University of Ottawa, Theravance Biopharma, Cytokinetics, Chemistry and Biomolecular Graduate Student Association (CBGSA), Queensway Carleton Hospital[45]
Xinying Wang RNA Scientist[7:38] -
John Williams Company Secretary (UK)[7:39] Institute of Chartered Accountants in England and Wales (ICAEW)
Kathy Wong Research Associate, RNA[7:40] British Columbia Centre for Disease Control (BCCDC)
Caroline Ye Senior Scientist I, Formulation[7:41] Precision NanoSystems, Imperial College London (ICL), Kastrup Lab, Cat Therapy & Rescue Society[46]

Patents

  1. NanoVation Therapeutics UK. Research Complex at Harwell. Retrieved September 11, 2024, from https://ghostarchive.org/archive/BoY51 ↩︎

  2. NMIN spin-off company NanoVation Therapeutics is expanding into UK. (2022, April 20). Nanomedicines Innovation Network. https://web.archive.org/web/20220525201917/https://www.nanomedicines.ca/2022/04/20/nanovation-expands-into-uk/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  3. OrgBook BC. (2023, October 15). NanoVation Therapeutics Inc. OpenCorporates. https://opencorporates.com/companies/ca_bc/BC1264242 ↩︎

  4. UK Companies House. (2024, July 1). NanoVation Therapeutics UK Ltd. OpenCorporates. https://opencorporates.com/companies/gb/13786991 ↩︎

  5. Innovate BC Awards $2.3M to B.C. R&D Projects. (2022, September 30). Innovate BC. https://web.archive.org/web/20220930020529/https://www.innovatebc.ca/en/news/innovate-bc-awards-2.3m-to-b.c.-rd-projects ↩︎

  6. NanoVation Therapeutics. Life Sciences British Columbia. Retrieved February 6, 2024, from https://web.archive.org/web/20240206065115/https://lifesciencesbc.ca/member/NanoVationTherapeutics/ ↩︎

  7. Team. NanoVation Therapeutics. Retrieved September 7, 2024, from https://web.archive.org/web/20240907003826/https://nanovationtx.com/team/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  8. Pieter Cullis. NanoVation Therapeutics. Retrieved September 6, 2024, from http://archive.today/2024.09.06-235013/https://nanovationtx.com/1cullis/ ↩︎

  9. Experience | Dominik Witzigmann. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/dominikwitzigmann/details/experience/ ↩︎

  10. Volunteering | Dominik Witzigmann. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/dominikwitzigmann/details/volunteering-experiences/ ↩︎

  11. Marion Athané. NanoVation Therapeutics. Retrieved September 6, 2024, from https://web.archive.org/web/20240906232247/https://nanovationtx.com/athane/ ↩︎

  12. Experience | Marion Athané. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/marion-athané-094a6560/details/experience/ ↩︎

  13. N. D. Prasad Atmuri, Ph.D. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/n-d-prasad-atmuri-ph-d-b6048957/ ↩︎

  14. Hanna Barriga. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/hanna-barriga-7a168442/ ↩︎

  15. Experience | Marshall Beck. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/marshall-beck-1308a040/details/experience/ ↩︎

  16. Experience | Mayara Brandao. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/mayarabr/details/experience/ ↩︎

  17. David Broemeling. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/david-broemeling/ ↩︎

  18. Frederick Campbell. NanoVation Therapeutics. Retrieved September 7, 2024, from https://web.archive.org/web/20240907001606/https://nanovationtx.com/campbellf/ ↩︎

  19. Fred Campbell. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/fred-campbell-916591228/ ↩︎

  20. Tony Cheung. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/tony-cheung-7725b647/ ↩︎

  21. Christine DeMatteis. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/christine-dematteis-32630b243/ ↩︎

  22. Experience | Arpan Desai. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/arpandesaiuk/details/experience/ ↩︎

  23. Experience | Allison Enjetti, MSc. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/allison-enjetti-msc-22397424/details/experience/ ↩︎

  24. Experience | Don Enns. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/don-enns-1b222a30/details/experience/ ↩︎

  25. Experience | Bruno Fonseca, PhD. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/bruno-fonseca-phd-a7279410/details/experience/ ↩︎

  26. Georgia Girt. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/georginagirt/ ↩︎

  27. Rupsa Gupta. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/rupsa-gupta-8a70b9129/ ↩︎

  28. Graham Hayes. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/graham-hayes-097122136/ ↩︎

  29. Kate Hollinshead. NanoVation Therapeutics. Retrieved September 6, 2024, from https://web.archive.org/web/20240906235900/https://nanovationtx.com/hollinshead/ ↩︎

  30. Joshua I.R. Jeyakumar. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/joshuaimmanuelj/ ↩︎

  31. Daniel Kurek. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/daniel-kurek-a0910789/ ↩︎

  32. Wendy Lamson. LinkedIn. Retrieved September 6, 2024, from https://www.linkedin.com/in/wendy-lamson-61a673a/ ↩︎

  33. Rafaela Marodin. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/rafaela-marodin/ ↩︎

  34. Michelle Martin, CPHR, SHRM-SCP. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/michelle-martin-cphr-shrm-scp-149bb07/ ↩︎

  35. Experience | Nigel McKenzie. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/nigelmckenzie/details/experience/ ↩︎

  36. Lívia Palmerston Mendes. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/liviapmendes/ ↩︎

  37. Experience | Ardalan Nabi. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/ardalan-nabi-8817401a2/details/experience/ ↩︎

  38. Experience | Ariane Miriam Nissenbaum. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/arianemn/details/experience/ ↩︎

  39. Grishma Pawar, Ph.D. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/grishma-pawar-ph-d-38b6ab18/ ↩︎

  40. Atul Kaushik Rangadurai, PhD. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/atul-rangadurai/ ↩︎

  41. Eleonore Rayner. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/eleonorerayner/ ↩︎

  42. Jessica Silva. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/jessica-afd-silva/ ↩︎

  43. Molly Stevens. NanoVation Therapeutics. Retrieved September 7, 2024, from https://web.archive.org/web/20240907002042/https://nanovationtx.com/stevens/ ↩︎

  44. Anthony T. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/anthony-t-ab200a20/ ↩︎

  45. Huy Tran, Ph.D. LinkedIn. Retrieved September 9, 2024, from https://www.linkedin.com/in/huytranchem/ ↩︎

  46. Caroline Ye. LinkedIn. Retrieved September 10, 2024, from https://www.linkedin.com/in/caroline-ye96/ ↩︎